The risk of several medical and psychiatric illnesses is higher in patients with psoriasis, but those prescribed biologic agents are less likely to develop the latter as compared to those not prescribed medications, according to a study.
Treatment with cyclosporine results in improvements, albeit statistically nonsignificant, in the Severity of Alopecia Tool score and eyelash and eyebrow assessment scales among patients with moderate-to-severe alopecia areata (AA), a recent study has shown.
Cardiovascular disease (CVD), haemoglobin ≤10 g/dL and body surface area involvement ≥10 percent on admission increase the risk of bacteraemia in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), reports a study.
The University of Cambridge, the Royal College of Physicians, London (RCP) and the Sunway Group have launched a collaborative continuing medical education (CME) seminar series for Malaysian healthcare professionals.
Use of cycline antibiotics (CAs) is associated with an elevated risk of pseudotumour cerebri syndrome (PTCS) or papilledema, suggests a recent study. However, no statistically significant link between CA use and PTCS development is seen when accounting for confounding factors.
The first-in-class interleukin (IL)-17A monoclonal antibody secukinumab is a safe and effective treatment for moderate-to-severe plaque psoriasis, with efficacy rates similar to those found in its phase III studies and enduring up to a year from start of treatment.
Bloodstream infections are common among patients with epidermal necrolysis and are mostly caused by Staphylococcus aureus and Pseudomonas aeruginosa, a recent study has found. Skin cultures may help predict such infections.
Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.
Men who undergo flexible cystoscopy, particularly with a longer dwell time, may benefit from intraurethral lidocaine as it provides significant pain reduction, suggest the results of a meta-analysis. Evidence is lacking for other tested interventions.